Negative results: Lötsch et al., 2009 found that the frequency of these same four genetic variants (29insA, rs1805007, rs 1805008, and rs1805009) in 352 people receving outpatient pain therapy did not differ significantly from that in the average Caucasian population, and were not associated with opiod dose, pain scores or side effects.